Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Adalimumab × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 1

Interventions

pembrolizumab 540 Specimen Handling 509 Magnetic Resonance Spectroscopy 438 Carboplatin 352 Cyclophosphamide 333 Biopsy 305 Cisplatin 295 Paclitaxel 265 Nivolumab 254 Gemcitabine 228 Radiotherapy 222 Bevacizumab 193 Dexamethasone 190 fludarabine 183 venetoclax 178 Oxaliplatin 159 Docetaxel 156 Fluorouracil 154 atezolizumab 153 durvalumab 152 Rituximab 148 Capecitabine 143 Pemetrexed 142 Doxorubicin 134 Radiation 131 Lenalidomide 128 Prednisone 124 Standard of Care 123 Radiosurgery 119 Drug Therapy 118

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06440629 2026-02-05

RA-DRUM

Diakonhjemmet Hospital

Phase 4 Recruiting

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡